News

Knight Therapeutics Inc. a leading pan-American (ex-US) specialty pharmaceutical company, announced the signing of a new exclusive distribution agreement with Gilead Sciences, Inc. for…
Read More...

Bayer AG announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing…
Read More...

ANA Therapeutics announced that it has begun a multicenter, Phase 2/3 clinical trial to evaluate the safety and efficacy of its proprietary, oral niclosamide (ANA001) formulation for…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators in the US, UK, Brazil, South Africa and Japan confirming that it…
Read More...

Gilead Sciences, Inc. announced the completion of the previously announced transaction to acquire Immunomedics, Inc. for approximately $21 billion in the aggregate. “We are very…
Read More...

Avalon GloboCare Corp. and Adial Pharmaceuticals, Inc. announced formation of a strategic collaboration for global distribution of the Assure/Fastep COVID-19 IgG/IgM Rapid Test device…
Read More...

Catalent and BrainStorm Cell Therapeutics Inc announced an agreement for the manufacture of NurOwn, BrainStorm’s autologous cellular therapy being investigated for the treatment of…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for branaplam (LMI070) in Huntington’s disease (HD). An Orphan Drug Designation…
Read More...

Teneobio, Inc., a clinical-stage biotechnology company developing engineered bispecific antibodies to treat cancer, announced that it has entered into a research collaboration and…
Read More...

Gilead Sciences, Inc. announced 48-week data from the BRAAVE 2020 study, a Phase 3 clinical trial evaluating the safety and efficacy of switching to Biktarvy (bictegravir 50…
Read More...

ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. a clinical-stage, natural killer cell-based therapeutics company, announced that the first patient has been…
Read More...

Purdue Pharma L.P. announced that it has entered into an agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the…
Read More...

HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has entered into a research collaboration and service agreement with Takeda Pharmaceutical Company…
Read More...

JSR Life Sciences, LLC announced that it is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its…
Read More...

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of ASP0367/MA-0211 (“ASP0367”) as a potential…
Read More...

Prothena Corporation plc a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare…
Read More...

Symvivo Corporation announced that it is receiving advisory services and funding of up to $2.8 million from the National Research Council Industrial Research Assistance Program (NRC…
Read More...

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company, which is the world leader in the testing of vaccines and antivirals using human challenge…
Read More...